Price war anticipated following approval of Amgen cancer drug
The FDA has approved Amgen’s colon-cancer drug Vectibix (panitumumab), setting the scene for a price war with rival drug Erbitux ...
Your Email Address: *
Recipient(s) Email Address: *
(Separate multiple e-mail addresses with commas. Limited to 20 addresses.)
The e-mail address(es) that you supply to use this service will only be used to send the requested article.